Paper Details

  1. Home
  2. Paper Details

Infliximab treatment maintains employability in patients with early rheumatoid arthritis.

Author: BakerDaniel, BalaMohan, BathonJoan M, EmeryPaul, HanChenglong, HanJohn, KaldenJoachim R, KeystoneEdward, MainiRavinder N, SchiffMichael, SmolenJosef S, St ClairE William, van der HeijdeDésirée

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

Patients with early RA who were treated with MTX plus infliximab had a higher probability of maintaining their employability compared with those who were treated with MTX alone.
Paper Details　
Original Abstract of the Article :
OBJECTIVE: To evaluate the impact of infliximab therapy on the employment status of patients with early rheumatoid arthritis (RA). METHODS: Methotrexate (MTX)-naive patients with active early RA were randomly allocated to receive MTX plus placebo or MTX plus infliximab (3 mg/kg or 6 mg/kg) at weeks...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1002/art.21661

データ提供：米国国立医学図書館（NLM）

Infliximab: Maintaining Employability in Early Rheumatoid Arthritis

This research investigates the impact of infliximab therapy on the employability of patients with early rheumatoid arthritis (RA), a debilitating autoimmune disease that can significantly impact quality of life. The authors examine the effects of infliximab on employment status, exploring its potential to maintain employability and improve patient well-being. This research is akin to navigating the desert of chronic illness, seeking strategies to maintain functionality and quality of life.

Infliximab: A Beacon of Hope in the Desert of Rheumatoid Arthritis

The study found that infliximab therapy, combined with methotrexate, significantly improved the likelihood of maintaining employability in patients with early RA compared to methotrexate alone. This finding is like discovering a hidden oasis in the desert of chronic illness, offering respite from the debilitating effects of the disease and the possibility of continuing a fulfilling life.

Maintaining Function: Navigating the Desert of Chronic Illness with Strategies

This research highlights the importance of early and effective treatment for RA, emphasizing the potential of infliximab to improve patient well-being and maintain employability. This underscores the need for continued research and development of new therapeutic approaches to manage this chronic condition, similar to seeking innovative solutions to navigate the challenges of a harsh desert environment.

Dr. Camel's Conclusion

This study suggests that infliximab therapy can play a significant role in maintaining employability in patients with early rheumatoid arthritis, offering a beacon of hope for individuals seeking to navigate the challenges of chronic illness and maintain a fulfilling life.

Date :
  1. Date Completed 2006-04-13
  2. Date Revised 2022-04-08
Further Info :

Pubmed ID

16508932

DOI: Digital Object Identifier

10.1002/art.21661

Related Literature

Article Analysis
・Effective treatment of rheumatoid arthritis
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.